When assessing significant expression differences for members of the CmPn network, our analysis revealed that decreased expression of CCM1, while increased expression of CCM2/CCM3 had worst prognostic effects in Luminal-A breast cancers (Fig. 2A), re-affirming our previous notion of the essential role of the CSC during breast cancer tumorigenesis. The gene discussed is CCM2; the disease is breast cancer.